Postoperative Nausea and Vomiting Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Space

November 09 14:23 2021
Postoperative Nausea and Vomiting Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Space
DelveInsight Business Research LLP
DelveInsight’s “Post-Operative Nausea & Vomiting – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Post-Operative Nausea & Vomiting, historical and forecasted epidemiology as well as the Post-Operative Nausea & Vomiting market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Postoperative Nausea and Vomiting – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Postoperative Nausea and Vomiting – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Postoperative Nausea and Vomiting, historical and forecasted epidemiology as well as the Postoperative Nausea and Vomiting market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Postoperative Nausea and Vomiting Market Report:

  • The total population of PONV in the 7MM was 17,264,097 in 2020, and this is expected to increase during the study period (2018–2030). Also, the estimates show the highest population of PONV is in the United States, followed by Japan.

  • According to estimates, in 2020, the total cases of PONV included 9,939,406 cases of patients with prophylactic antiemetics: nausea and vomiting, and 2,288,058 cases without it in the United States. 

  • Among the EU5 countries, in 2020, Germany had the highest population of PONV, followed by Italy, which had a population of 404,997, and Spain had the lowest population of PONV, i.e.  291,610.

Key benefits of the report:

  1. Postoperative Nausea and Vomiting market report covers a descriptive overview and comprehensive insight of the Postoperative Nausea and Vomiting Epidemiology and Postoperative Nausea and Vomiting  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Postoperative Nausea and Vomiting market report provides insights on the current and emerging therapies.

  3. Postoperative Nausea and Vomiting market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Postoperative Nausea and Vomiting market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Postoperative Nausea and Vomiting market.

Got queries? Click here to know more about the Postoperative Nausea and Vomiting Market Landscape.

Postoperative Nausea and Vomiting Overview

Postoperative nausea and vomiting (PONV) is an enormous problem for patients recovering after surgery. About one-third of people experience vomiting, and half of them experience nausea. Nausea, retching, or vomiting usually occurs during the first 24–48 h after surgery in inpatients. Also, PONV is a common side effect following sedation and general anesthesia.

The consequences of PONV can include increased anxiety for future surgical procedures, increased recovery time and hospital stay, and in severe cases, aspiration pneumonia, incisional hernia or suture dehiscence, bleeding esophageal rupture, and metabolic alkalosis. The causes of the PONV are related to the patient and preoperative, intraoperative, and postoperative factors such as pharyngeal stimulation, opioid medication, hypoxia, hypertension, etc.

Postoperative Nausea and Vomiting Market 

The dynamics of the Postoperative Nausea and Vomiting market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Vivozon, Avenue Therapeutics, Taiwan Liposome Company, and others during the forecasted period 2018-2030.

Postoperative Nausea and Vomiting Pipeline Therapies and Key Companies 

  • CR845 (difelikefalin): Cara Therapeutics

  • CAM2058: Camurus/Braeburn

Postoperative Nausea and Vomiting Market Drivers 

  • Increase in research and development

  • Rise in awareness

  • Research in the genomic association of PONV

  • The rise in the number of surgeries

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Postoperative Nausea and Vomiting Patient Share (%) Overview at a Glance

5. Postoperative Nausea and Vomiting Market Overview at a Glance

6. Postoperative Nausea and Vomiting Disease Background and Overview

7. Postoperative Nausea and Vomiting Epidemiology and Patient Population

8. Country-Specific Patient Population of Postoperative Nausea and Vomiting 

9. Postoperative Nausea and Vomiting Current Treatment and Medical Practices

10. Unmet Needs

11. Postoperative Nausea and Vomiting Emerging Therapies

12. Postoperative Nausea and Vomiting Market Outlook

13. Country-Wise Postoperative Nausea and Vomiting Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Postoperative Nausea and Vomiting Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Postoperative Nausea and Vomiting Market Outlook 2030.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

view more articles

About Article Author